Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Side Effects and Tolerability While GLP-1 medications are generally well tolerated, some patients may experience side effects like nausea, vomiting, or stomach discomfort
Growing Adoption of Self-Injectable Pens & Oral Tablets Pre-filled FlexTouch pens achieve 12-month adherence rates of above 70%, compared to 5060% for daily oral medications
UK considerations NHS and MHRA guidance The UK health authorities have clear positions on weight loss treatments: The NHS offers GLP-1 medications through specialist weight management services for eligible patients MHRA has approved Wegovy, Saxenda, and Mounjaro based on comprehensive safety and efficacy data No GLP-1 patch products have received MHRA approval as weight loss treatments The MHRA has issued warnings about misleading claims in weight loss supplements Cost and access in the UK The financial aspect is a significant consideration for many: NHS provision : Limited availability through specialist weight management services with strict eligibility criteria Private prescriptions : 150-300 monthly, depending on medication and provider Commercial patches : 12-70 monthly, depending on brand and quantity While patches appear less expensive, they lack evidence of effectiveness, making them poor value regardless of price
QWO Originally used under the name XIAFLEX to treat adults suffering from Dupuytrens contracture, QWO is an injectable solution made up of collagenase clostridium histolyticum, which works to reduce and eliminate cellulite by breaking down the fibrous septae pulling down the skin which causes the classic dimpling seen in cellulite patients
The safety of our programs is a top priority
Tendon and ligament injuries (stalled recovery): Patients with subacute tendinopathy that has plateaued in PT typically notice a meaningful change in pain level and range of motion within 3 to 4 weeks
